Recordati | REC - Cash And Equivalent

Stock Price
45.22
Daily Change
0.18 0.40%
Monthly
-5.04%
Yearly
-15.16%
Q1 Forecast
44.07

Recordati reported EUR471.46M in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
Almirall EUR 337.77M 14.83M Dec/2025
GlaxoSmithKline GBP 3.3B 303M Sep/2025
Hikma Pharmaceutical USD 236M 48M Jun/2025
Orion EUR 160.9M 63.3M Dec/2025
Sanofi EUR 7.66B 1.25B Dec/2025